Precision Oncology Conferences

Our conferences distill the latest precision oncology advances enabling you to accelerate the development of more effective cancer treatments for targeted patient populations.

Covering the breadth of precision oncology drug development, our sector-defining conferences on ADCs, targeted radiopharmaceuticals, companion diagnostics, and bispecifics provide the insight you need to deliver more effective treatments for patients in need.

0

5th Targeted Radiopharmaceuticals Summit US

July 2026

Translating Novel Radiopharmaceutical Therapies to Transform the Medical Future

Precision Oncology

Conference

14th Tumor Models Boston Summit

July 2026

Interrogate Model Selection Rationale, De-Risk Clinical Translation

Precision Oncology

Conference

8th RAS-Targeted Drug Development Summit

September 2026

Powering the Development of Broad-Spectrum, Durable RAS Therapeutics

Precision Oncology

Conference

17th World Bispecific Summit

September 2026

Accelerating Safer, More Efficacious Bispecifics, Multispecifics & Cell Engagers

Precision Oncology

Conference

8th Targeted Radiopharmaceuticals Summit EU

December 2026

Advancing Radioligand Candidates to Commercialisation

Precision Oncology

Conference

15th Tumour Models London Summit

December 2026

Engineering Your Next Generation Tumour Models to Maximise Clinical Success

Precision Oncology

Conference

2nd T-Cell Engager Therapeutics Summit Europe

December 2026

Optimise Targeting, Reduce On-Target Off-Tumour Toxicities & Accelerate Immunotherapies

Precision Oncology

View and search all of our conferences.

View All Conferences

Accelerating the Development of More Efficacious Precision Oncology Therapeutics

Testimonials

“I’m looking forward to attending and presenting at the World Clinical Biomarkers & CDx Summit. This is a key meeting for researchers, biomarker developers and Pharma to connect and shape the future of Precision Medicine.”

Amy Gorman

Director, Global Commercial Strategy, Precision Medicine, Janssen

“This conference has been very insightful in the past as the field of CDx is still advancing and we can learn from each other’s experiences.”

Silva Krause

Senior Director, Clinical Biomarkers, Vertex Pharmaceuticals

“Very rewarding. Resulted in several big pharma collaborations.”

Co-Founder & CEO, Aracari Biosciences

“Really enjoyed the conference. Great integration with speakers and delegates. The small size made it easier to make connections. Overall, the quality of the speakers and delegates was very high. I would definitely recommend it and hope to return next year.”

Group Lead, Gamma Delta Therapeutics

What to Expect at Hanson Wade Conferences?